A critical breakthrough in cancer study is arising with the use of nanobodies to reactivate damaged p53. This crucial cancer inhibitor protein is frequently disabled in several forms of tumors, resulting uncontrolled https://social-medialink.com/story7016922/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-approach-for-tumor-therapy